These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15922)

  • 1. Medical management of Crohn's disease in adolescence.
    Whittington PF; Barnes HV; Bayless TM
    Gastroenterology; 1977 Jun; 72(6):1338-44. PubMed ID: 15922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate-day prednisone treatment and treatment maintenance in Crohn's disease.
    Bello C; Goldstein F; Thornton JJ
    Am J Gastroenterol; 1991 Apr; 86(4):460-6. PubMed ID: 1672787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA; Hanauer SB; Kirschner BS
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
    Singleton JW; Summers RW; Kern F; Becktel JM; Best WR; Hansen RN; Winship DH
    Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
    Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
    Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis in children with Crohn's disease.
    Gryboski JD; Spiro HM
    Gastroenterology; 1978 May; 74(5 Pt 1):807-17. PubMed ID: 25221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
    Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA
    Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Cooperative Crohn's Disease Study: results of drug treatment.
    Summers RW; Switz DM; Sessions JT; Becktel JM; Best WR; Kern F; Singleton JW
    Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Cooperative Crohn's Disease Study: adverse reactions to study drugs.
    Singleton JW; Law DH; Kelley ML; Mekhjian HS; Sturdevant RA
    Gastroenterology; 1979 Oct; 77(4 Pt 2):870-82. PubMed ID: 38177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pediatric corner: the varied manifestations of Crohn's disease in children and adolescents.
    Dubois RS; Rothschild J; Silverman A; Sabra A
    Am J Gastroenterol; 1978 Feb; 69(2):203-11. PubMed ID: 27092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ; Feagan BG; Lichtenstein GR
    Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug treatment of Crohn's disease].
    van Deventer SJ; Tytgat GN
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Crohn's disease in children and adolescents].
    Le Luyer B; Morin CL; Roy CC; Weber A; Chouraqui JP; Bensoussan A
    Arch Fr Pediatr; 1985 Oct; 42(8):677-82. PubMed ID: 2866758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
    Singleton JW
    Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutical experiments in ulcerative colitis and Crohn's disease.
    Nagy G; Prónay G; Ujszászy L
    Acta Med Hung; 1985; 42(3-4):163-74. PubMed ID: 2869469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Cooperative Crohn's Disease Study: study design and conduct of the study.
    Winship DH; Summers RW; Singleton JW; Best WR; Becktel JM; Lenk LF; Kern F
    Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.